Controlled Substances - As enacted, authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone; adds that prescribing a buprenorphine product to nursing mother or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for the treatment of opioid use disorder without naloxone. - Amends TCA Title 53, Chapter 11.
1
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
2
Where do you stand?
Choose your position
3
Tell your reps
Take a position to see your representatives and ways to contact them.